Trial Profile
Combined HIV Adolescent PrEP and Prevention: On Demand Pre-exposure Prophylaxis to Provide Protection From HIV in Men - Using Foreskin Tissue to Estimate Protection (Phase II)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Aug 2022
Price :
$35
*
At a glance
- Drugs Emtricitabine (Primary) ; Tenofovir alafenamide (Primary) ; Tenofovir disoproxil fumarate (Primary)
- Indications HIV infections; HIV-1 infections
- Focus Pharmacodynamics
- Acronyms CHAPS
- 02 Aug 2022 Results assessing ex-vivo HIV suppression in foreskin tissue after oral dosing of F/TDF and F/TAF in young South African males, presented at the 24th International AIDS Conference.
- 29 Jul 2022 Status changed from recruiting to completed.
- 16 Feb 2022 Results presented at the 29th Conference on Retroviruses and Opportunistic Infections